| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.08 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |